Astria Therapeutics Inc
:CATB
Products, Exchange Changes, Regulatory
Catabasis Pharmaceuticals Renames To Astria Therapeutics
Published: 09/08/2021 12:37 GMT
(CATB) - Catabasis Pharmaceuticals Announces New Company Name, Astria Therapeutics.
Catabasis Pharmaceuticals Inc - Expects to Begin Trading Under New Ticker Symbol "atxs" on Nasdaq Global Select Market at Market Open on September 9.
Catabasis Pharmaceuticals Inc - Expects to File Ind Application for Star-0215 in Mid-2022.
Catabasis Pharmaceuticals - Plans to Initiate Phase 1 Clinical Trial With Initial Proof of Concept Results Anticipated by Year End 2022 for Star-0125.
Catabasis Pharmaceuticals Inc - Expects to Begin Trading Under New Ticker Symbol "atxs" on Nasdaq Global Select Market at Market Open on September 9.
Catabasis Pharmaceuticals Inc - Expects to File Ind Application for Star-0215 in Mid-2022.
Catabasis Pharmaceuticals - Plans to Initiate Phase 1 Clinical Trial With Initial Proof of Concept Results Anticipated by Year End 2022 for Star-0125.